Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:03 PM
Ignite Modification Date:
2025-12-24 @ 5:03 PM
NCT ID:
NCT00308750
Eligibility Criteria:
Inclusion Criteria:
* You must have been diagnosed with NSCLC.
* You must be able to visit the doctor's office weekly during the active treatment period and as needed during the study follow-up period.
* You must be willing and able to swallow capsules.
* Your entry labs and medical tests must meet study requirements.
* You must be willing to have blood samples drawn and tissue samples obtained for gene and protein testing.
Exclusion Criteria:
* You have received radiation within 2 weeks of study enrollment.
* You have previously received any anti-cancer drug therapy for NSCLC.
* You have an active infection or other serious condition.
* You take aspirin or aspirin-like medication regularly and are not able to stop taking them for a few days during each cycle of chemotherapy.
* You have recently lost a significant amount of weight.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00308750
Study Brief:
Protocol Section:
NCT00308750